TransMedics Group announced a strategic investment in Germany-based private aviation operator PAD Aviation to support the expansion of its Organ Care System National OCS Program into Europe. The partnership aims to increase adoption of the company's OCS perfusion technology and establish a dedicated pan-European air and ground logistics network for organ transportation across the European Union. TransMedics expects the collaboration to improve access to donor organs, streamline transplant logistics, and increase transplant opportunities for patients throughout Europe. Separately, Evercore ISI analyst Daniel Markowitz lowered the price target on TransMedics to $90 from $100 while maintaining an Outperform rating, citing stable procedure volumes and capital spending trends across the MedTech sector.
TransMedics Group IncInvestment in PAD Aviation aims to expand OCS program into Europe, increasing adoption and transplant opportunities.
Evercore Partners IncStrategic investment from TransMedics will expand PAD Aviation's role in organ transportation logistics across Europe.